DUSA PHARMACEUTICALS, INC.
NASDAQ : DUSA

DUSA PHARMACEUTICALS, INC.

August 15, 2007 08:01 ET

DUSA Pharmaceuticals to Present at the Noble Financial Two Double-0-Seven Conference

WILMINGTON, MASSACHUSETTS--(Marketwire - Aug. 15, 2007) - DUSA Pharmaceuticals, Inc.® (NASDAQ GM:DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, will present at the Noble Financial Two Double-0-Seven Small Cap Conference/Micro Cap Symposium Conference being held August 20 and 21, 2007 at the Charleston Place Hotel in Charleston, South Carolina.

On Monday, August 20 at 4:30 p.m. Bob Doman, President and Chief Executive Officer, will give a 25-minute presentation regarding DUSA's history, products, financial performance and prospects. Mr. Doman and Rich Christopher, the Company's VP Finance and Chief Financial Officer will also participate in a question and answer session following the presentation and one-on-one meetings throughout the conference.

The presentation with streaming video and PowerPoint presentation will be webcast live and archived on DUSA's website at www.dusapharma.com and Noble Financial's conference website at www.two-007.net. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT) technology platform, and complementary dermatology products. Levulan PDT is currently approved for the treatment of Grade 1 or Grade 2 actinic keratoses of the face or scalp, and is being studied for the treatment of acne. DUSA's other dermatology products include ClindaReach™, Nicomide® and the AVAR® line. DUSA is also researching additional indications for internal uses of Levulan PDT. DUSA is based in Wilmington, MA. Please visit the company's website at www.dusapharma.com for more information.

About Noble Financial

Noble Financial is a privately-held, full-service capital markets firm driven by what is often overlooked by other firms - uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales & trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences - 2007 marks their third annual - allow for a unique blend of professional and personal interaction among a diverse cross-section of executives. The company has operated for 23 years and has offices in Florida and New York City.

Conference Information: www.two-007.net or info@two-007.net.

Investor Registration: www.two-007.net/RegistrationInvestorBuyside.htm

Noble Financial Website: www.nobleresearch.com

Contact Information

  • DUSA Pharmaceuticals, Inc.
    Shari Lovell
    Director, Shareholder Services
    (978) 657-7500 Ext. 1121
    Website: www.dusapharma.com
    or
    The Trout Group LLC
    Seth Lewis
    Investor Relations Contact
    (617) 583-1308